Alkylation of [3H]8-OH-DPAT binding sites in rat cerebral cortex and hippocampus

Zifa, E., and Fillion, G. 1992. 5-Hydroxytryptamine receptors. Pharmacol. Rev. 44:401–458.

Humphrey, P. P. A., Hartig, P., and Hoyer, D. 1993. A proposed new nomenclature for 5-HT receptors TIPS 14:233–235.

Peroutka, S. J. 1993. 5-Hydroxytryptamine receptors. J. Neurochem. 60:408–416.

Gozlan, H., ElMestikawy, S., Pichat, L., Glowinski J., and Hamon, M. 1983. Identification of presynaptic serotonin autoreceptors using a new ligand:3H-PAT. Nature 305:140–142.

Hall, M., ElMestikawy, S., Emerit, M. B., Pichat, L., Hamon, M., and Gozlan, H. 1985. [3H]8-hydroxy-2-(Di-n-Propylamino) tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J. Neurochem. 44:1685–1695.

Vergé, D., Daval, G., Marcinkiewicz, M., ElMestikawy, S., Gozlan, H., and Hamon, M. 1986. Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J. Neurosci. 6:3474–3482.

Radja, F., Laporte, A.M., Daval, G., Vergé, D., Gozlan, H., and Hamon, M. 1991. Autoradiography of serotonin receptor subtypes in the central nervous system. Neurochem. Int. 18:1–15.

Radja, F., Descarries, L., Dewar, K.M., and Reader T. A. 1993. Serotonin 5-HT1 and 5-HT2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autoradiographic study. Brain Res. 606:273–285.

Miquel, M. C., Doucet, E., Riad, M., Adrien, J., Vergé, D., and Hamon, M. 1992. Effect of the selective lesion of serotoninergic neurons on the regional distribution of 5-HT1A receptor mRNA in the rat brain. Molec. Brain. Res. 14:357–362.

Bolaños, F. J., Schechter, L. E., Laporte, A. M., Hamon, M., and Gozlan, H. 1992. Recovery of 5-HT1A receptors after irreversible blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Proc. West Pharmacol. Soc. 34:387–393.

Fletcher, A., Cliffe, I. A., and Dourish, C. T. 1993. Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents. TIPS 14:441–448.

Cox, R. F., Meller, E., and Waszczak, B. L. 1993. Electrophysiological evidence for a large receptor reserve for inhibition of doral raphe neuronal firing by 5-HT1A agonists. Synapse 14:297–304, 1993.

Yocca, F. D., Iben, L., and Meller, E. 1992. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes. Molec. Pharmacol. 41:1066–1072.

Jolas, T., Haj-Dahmane, S., Kidd, E. J., Langlois, X., Lanfumey, L., Fattaccini, C. M., Vantalon, V., Laporte, A. M., Adrien, J., Gozlan, H., and Hamon, M. 1994. Central pre-and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J. Pharmacol. Exp. Ther. 268:1432–1443. 1994.

Crin, P. B., Vogt, B. A., Volicer, L., and Wiley, R. G. 1990. Cellular localization of serotonin 1A, 1B and uptake sites in cingulate cortex of the rat. J. Pharmacol. Exp. Ther. 252:651–656.

Dumuis, A., Sebben, M., and Bockaert, J. 1988. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture. Mol. Pharmacol. 33:178–186.

Nénonéné, E. K., Radja, F., Carli, M., Grondin, L., and Reader, T. A. 1994. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]h hydroxydipropylaminotetralin. J. Neurochem. 62:1822–1834.

Schoemaker, H., and Langer, S. Z. 1986. [3H]8-OH-DPAT labels the serotonin transporter in the rat striatum. Eur. J. Pharmacol. 124:371–373.

Sprouse, J. S., McCarty, D. R., and Dudley, M. W. 1993. Apparent regional differences in 5-HT1A binding may reflect [3H]8-OH-DPAT labeling of serotonin uptake sites. Brain Res. 617:159–162. 1993.

Torchinsky, Y. M. 1981. The chemical properties of SH groups; Sulfhydryl reagents. In:Sulfur in proteins. Metzler, D., ed., Pergamon Press, Oxford, New York, Toronto, pp 3–7.

Cleland, W. W. 1964. Dithiothreitol, a new protective reagent for SH groups. Biochemistry 3:480–482.

Giorgi, O., and Biggio, G. 1990. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists. Brain Res. 533:53–59.

Pilc, A., and Vetulani, J. 1990. Pretreatment withN-ethoxycarbony-1-2-ethoxy-1,2-dihydroquinoline accelerates the electroshock-induced decrease in the density of β-adrenoceptors but not fucntional downregulation. Neuropharmacology 29:469–473.

Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurements with Folin phenol reagent. J. Biol. Chem. 193:265–275.

Parker, R. B., and Waud, D. R. 1971. Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J. Pharmacol. Exp. Ther. 177:1–12.

Barlow, R. B. 1983.Biodata Handling with Microcomputers, Elsevier Science Publishers, Amsterdam.

De Léan, A., Munson, P. J., and Rodbard, D. 1978. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiologicaldose-response curve. Am. J. Physiol. 235:E97-E102.

Munson, P. J., and Rodbard, D. 1980. LIGAND: A versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem. 107:220–239.

McPherson, G. A. 1985. Analysis of radioligand binding experiments: A collection of computer programs for the IBM PC. J. Pharmacol. Meth. 14:213–228.

Pauwels, P. J., Van Gompel, P., and Leysen, J. E. 1993. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HELA cells. Biochem. Pharmacol. 45:375–383, 1993.

Liau, L. M., Sleight, A. J., Pitha, J., and Peroutka, S. J. 1991. Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonist. Pharmacol. Biochem. Behav. 38:555–559.

Glennon, R. A., Naiman, N. A., Pierson, M. E., Titeler, M., Lyon, R., and Weisberg E. 1988. NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur. J. Pharmacol. 154:339–341.

Fletcher, A., Bill, D. J., Bill, S. J., Cliffe, I. A., Dover, G. M., Forster, E. A., Haskins, J. T., Jones, D., Mansell, H. L., and Reilly, Y. 1993. WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors. Eur. J. Pharmacol. 237:283–291.

Sundaram, H., Newman-Tancredi, A., and Strange, P. G. 1993. Characterization of recombinant human serotonin 5-HT1A receptors expressed in chinese hamster ovary cells. [3H]Spiperone discriminates between G-protein-coupled and-uncoupled forms. Biochem. Pharmacol. 45:1003–1009.

Newman, R. S., and Zebrowska, G. 1992. Serotonin (5-HT2) receptor mediated enhancement of cortical unit activity. Can. J. Physiol. Pharmacol. 70:1604–1609.

Radja, F., Daval, G., Hamon, M., and Vergé, D. 1992. Pharmacological and physico-chemical properties of pre-versus postsynaptic 5-HT1A receptor binding sites in the rat brain. J. Neurochem. 52:1338–1346.

Rydelek-Fitzgerald L., Teitler, M. Fletcher, P. W., Ismaiel, A. M., and Glennon, R. P. 1990. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors. Brain Res. 532:191–196.

Kitamura, Y., and Nomura, Y. 1987. Uncoupling of rat cerebral cortical α2-adrenoceptors from GTP-binding proteins byN-ethylmaleimide. J. Neurochem. 49:1894–1901.

Stratford, C. A., Tan, G. L., Hamblin, M. W., and Ciaranello, R. D. 1988. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain. Molec. Pharmacol. 34:527–536, 1988.

Ariani, K., Hamblin, M. W., Tang, G. L., Stratford, C. A., and Ciaranello, R. D. 1989. G protein dependent alterations in [125I]iodo-cyanopindolol and ±cyanopindolol binding at 5HT1B binding sites in rat brain membranes. Neurochem. Res. 14:835–843.

Bolaños, F. J., Schechter, L. E., Miquel, M. C., Emerit, M. B., Rumigny, J. F., Hamon, M., and Gozlan, H. 1990. Common pharmacological and physico-chemical properties of 5HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells. Biochem. Pharmacol. 40:1541–1550.

Brewer, C. F., and Riehm, J. P. 1967. Evidence for possible non-specific reactions betweenN-ethylmaleimide and proteins. Anal. Biochem. 18:248–255.

Miquel, M. C., Emerit, M. B., Gozlan, H., and Hamon, M. (1991). Involvement of tryptophan residue(s) in the specific binding of agonists/antagonists to 5-HT3 receptors in NG108-15 clonal cells. Biochem. Pharmacol. 42:1453–1461, 1991.

Scatchard, G. 1949. The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51:660–672.

Belleau, B., DiTullio, V., and Godin, D. 1969. The mechanism of irreversible adrenergic blockade byN-carbethoxydihydroquinolines. Model studies with typical serine hydrolases. Biochem. Pharmacol. 18:1039–1044.

Lovenberg, T. W., Baron, B. M., de Lecea, L., Miller, J. D., Prosser, R. A., Rea, M. A., Foye, P. E., Racke, M., Slone, A. L., Siegel, B. W., Danielson, P. E., Sutcliffe, J. G., and Erlander, M. G. 1993. A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 11:449–458.

Plassat, J.-C., Amlaiky, N., and Hen, R. 1993. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Molec. Pharmacol. 44:229–236.

Kawahara, F., Saito, H., and Katsuki, H. 1994. Inhibition by 5-HT7 receptor stimulation of GABAA receptor-activated current in cultured rat suprachiasmatic neurones. J. Physiol. 478:67–73.

Emerit, M. B., Miquel, M. C., Gozlan, H., and Hamon, M. 1991. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(Di-n-Propylamino) tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor. J. Neurochem. 56:1705–1716.